Blog
Should Laboratory Developed Tests (LDTs) be available to the general population before they have been fully demonstrated to work?
How can you spot fraudulently recruited COVIDera Hereditary Cancer Tests?
Caris Life Sciences Pays Over $2.8 Million to Settle False Claims Act Allegations from Delay in Submission of Genetic Cancer Screening Tests
Illumina Cybersecurity Vulnerability May Present Risks for Patient Results and Customer Networks
FDA Safety Communication for Patients and Healthcare Providers on NIPS
FDA Control of Laboratory Developed Tests (LDTs) Building Momentum with VALID Act
Natera and CareDx Fined Millions for False Advertising Associated with Inappropriate Marketing for Testing
